SI1862455T1 - 11-((4R,6R)-4,5,6-trihidroksi-3-(R)-hidroksi-2-(S)-hidroksi- heksikarbamoil)-undekanojska kislina - Google Patents

11-((4R,6R)-4,5,6-trihidroksi-3-(R)-hidroksi-2-(S)-hidroksi- heksikarbamoil)-undekanojska kislina

Info

Publication number
SI1862455T1
SI1862455T1 SI200431100T SI200431100T SI1862455T1 SI 1862455 T1 SI1862455 T1 SI 1862455T1 SI 200431100 T SI200431100 T SI 200431100T SI 200431100 T SI200431100 T SI 200431100T SI 1862455 T1 SI1862455 T1 SI 1862455T1
Authority
SI
Slovenia
Prior art keywords
hydroxy
hexylcarbamoyl
trihydroxy
undecanoic acid
undecanoic
Prior art date
Application number
SI200431100T
Other languages
English (en)
Inventor
Gerhard Dr Jaehne
Wendelin Dr Frick
Andreas Dr Lindenschmidt
Stefanie Dr Flohr
Hubert Dr Heuer
Hans-Ludwig Schaefer
Werner Prof Dr Kramer
Eric Dr Galia
Heiner Dr Glombik
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of SI1862455T1 publication Critical patent/SI1862455T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SI200431100T 2003-04-01 2004-03-16 11-((4R,6R)-4,5,6-trihidroksi-3-(R)-hidroksi-2-(S)-hidroksi- heksikarbamoil)-undekanojska kislina SI1862455T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10314610A DE10314610A1 (de) 2003-04-01 2003-04-01 Neues Diphenylazetidinon mit verbesserten physiologischen Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindungen enthaltende Arzneimittel und dessen Verwendung
EP07016889A EP1862455B1 (de) 2003-04-01 2004-03-16 11-((4R,6R)-4,5,6-Trihydroxy-3-(R)-hydroxy-2-(S)-hydroxy-hexylcarbamoyl)-Undekansäure

Publications (1)

Publication Number Publication Date
SI1862455T1 true SI1862455T1 (sl) 2009-06-30

Family

ID=33103147

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200430681T SI1613589T1 (sl) 2003-04-01 2004-03-16 Novi difenilazetidinon z izboljšanimi fiziološkimi lastnostmi, postopek za njegovo pripravo, zdravilo, ki vsebuje to spojino, in njegova uporaba
SI200431100T SI1862455T1 (sl) 2003-04-01 2004-03-16 11-((4R,6R)-4,5,6-trihidroksi-3-(R)-hidroksi-2-(S)-hidroksi- heksikarbamoil)-undekanojska kislina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SI200430681T SI1613589T1 (sl) 2003-04-01 2004-03-16 Novi difenilazetidinon z izboljšanimi fiziološkimi lastnostmi, postopek za njegovo pripravo, zdravilo, ki vsebuje to spojino, in njegova uporaba

Country Status (44)

Country Link
US (2) US7205290B2 (sl)
EP (2) EP1613589B1 (sl)
JP (1) JP2006522040A (sl)
KR (1) KR20050119180A (sl)
CN (2) CN100361970C (sl)
AR (1) AR043783A1 (sl)
AT (2) ATE386020T1 (sl)
AU (1) AU2004226287B2 (sl)
BR (1) BRPI0408920A (sl)
CA (1) CA2520689A1 (sl)
CL (1) CL43489B (sl)
CR (1) CR7995A (sl)
CY (2) CY1107398T1 (sl)
DE (3) DE10314610A1 (sl)
DK (2) DK1862455T3 (sl)
EC (1) ECSP056071A (sl)
ES (2) ES2322876T3 (sl)
GT (1) GT200400058A (sl)
HK (1) HK1087697A1 (sl)
HN (1) HN2004000109A (sl)
HR (1) HRP20050870A2 (sl)
JO (1) JO2493B1 (sl)
MA (1) MA27753A1 (sl)
ME (1) MEP41408A (sl)
MX (1) MXPA05010128A (sl)
MY (1) MY136269A (sl)
NI (1) NI200500164A (sl)
NO (1) NO20055001L (sl)
NZ (1) NZ542751A (sl)
PA (1) PA8599401A1 (sl)
PE (1) PE20050011A1 (sl)
PL (2) PL1613589T3 (sl)
PT (2) PT1613589E (sl)
RS (1) RS51146B (sl)
RU (1) RU2334737C2 (sl)
SA (1) SA04250154B1 (sl)
SI (2) SI1613589T1 (sl)
SV (1) SV2004001756A (sl)
TN (1) TNSN05244A1 (sl)
TW (1) TW200504009A (sl)
UA (1) UA80754C2 (sl)
UY (1) UY28253A1 (sl)
WO (1) WO2004087655A1 (sl)
ZA (1) ZA200506708B (sl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0116325A (pt) * 2000-12-21 2003-10-14 Aventis Pharma Gmbh 1,2-difenilazetidinonas, processos para a sua preparação, medicamentos contendo estes compostos e sua aplicação para o tratamento de distúrbios do metabolismo de lipìdios
CN101243072A (zh) 2005-06-20 2008-08-13 先灵公司 用作组胺h3拮抗剂的哌啶衍生物
US7067689B1 (en) 2005-07-08 2006-06-27 Microbia, Inc. Process for production of pentahydroxyhexylcarbamoyl alkanoic acids
BRPI0715160A2 (pt) 2006-08-08 2013-06-11 Sanofi Aventis imidazolidina-2,4-dionas substituÍdas por arilamimoaril-alquil-, processo para preparÁ-las, medicamentos compeendendo estes compostos, e seu uso
DE102007029612A1 (de) * 2007-06-27 2009-01-08 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Pentahydroxyhexylcarbamoylundekan- säurebenzylester
US20080319221A1 (en) * 2007-06-22 2008-12-25 Bernd Junker Esters of Pentahydroxyhexylcarbamoyl Alkanoic Acids
US20080319218A1 (en) * 2007-06-22 2008-12-25 Andreas Haubrich Processes for Making and Using Benzyl Pentahydroxyhexylcarbamoylundecanoate
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE102007063671A1 (de) * 2007-11-13 2009-06-25 Sanofi-Aventis Deutschland Gmbh Neue kristalline Diphenylazetidinonhydrate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
CN101939009B (zh) * 2008-02-05 2013-07-17 哈博生物科学公司 药学固体形式
WO2009112203A1 (de) * 2008-03-14 2009-09-17 Sanofi-Aventis Deutschland Gmbh Verfahren zur herstellung eines diphenylazetidinons
DE102008059772A1 (de) 2008-12-01 2010-06-02 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung eines Diphenylazetidinons
DE102010015123A1 (de) 2010-04-16 2011-10-20 Sanofi-Aventis Deutschland Gmbh Benzylamidische Diphenylazetidinone, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
EP2582709B1 (de) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
EP2683702B1 (de) 2011-03-08 2014-12-24 Sanofi Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
US8828995B2 (en) 2011-03-08 2014-09-09 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
WO2012120052A1 (de) 2011-03-08 2012-09-13 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683698B1 (de) 2011-03-08 2017-10-04 Sanofi Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2012120057A1 (de) 2011-03-08 2012-09-13 Sanofi Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683701B1 (de) 2011-03-08 2014-12-24 Sanofi Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120055A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8828994B2 (en) 2011-03-08 2014-09-09 Sanofi Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
US10426480B2 (en) * 2015-04-29 2019-10-01 Covidien Lp Cutting ring assembly with rigid cutting member

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663336B1 (fr) 1990-06-18 1992-09-04 Adir Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5756740A (en) * 1992-04-08 1998-05-26 Eastman Kodak Company Process for the preparation of binary sensitizing dyes
FR2713225B1 (fr) 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
HUP9902056A3 (en) 1996-01-17 2002-02-28 Novo Nordisk As Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
JP3149958B2 (ja) 1996-08-30 2001-03-26 ノボ ノルディスク アクティーゼルスカブ Ｇｌｐ―１誘導体
US5756470A (en) * 1996-10-29 1998-05-26 Schering Corporation Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
DE19726167B4 (de) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
WO1999003861A1 (en) 1997-07-16 1999-01-28 Novo Nordisk A/S Fused 1,2,4-thiadiazine derivatives, their preparation and use
CO4970713A1 (es) 1997-09-19 2000-11-07 Sanofi Synthelabo Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen
AU756965B2 (en) 1998-03-12 2003-01-30 Microbial Chemistry Research Foundation Benzofurylpyrone derivatives
US6221897B1 (en) 1998-06-10 2001-04-24 Aventis Pharma Deutschland Gmbh Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
DE19845405C2 (de) 1998-10-02 2000-07-13 Aventis Pharma Gmbh Arylsubstituierte Propanolaminderivate und deren Verwendung
CZ295768B6 (cs) 1998-12-07 2005-10-12 Societe De Conseils De Recherches Et D'application Analogy GLP-1, mající beta-alanin na pozici 35, jejich použití a farmaceutické prostředky je obsahující
GB9900416D0 (en) 1999-01-08 1999-02-24 Alizyme Therapeutics Ltd Inhibitors
JP4598278B2 (ja) 1999-04-28 2010-12-15 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Ｐｐａｒ受容体リガンドとしてのジアリール酸誘導体
SK15522001A3 (sk) 1999-04-28 2002-06-04 Aventis Pharma Deutschland Gmbh Deriváty kyselín s tromi arylovými zvyškami ako ligandy receptorov PPAR a farmaceutické kompozície, ktoré ich obsahujú
GB9911863D0 (en) 1999-05-21 1999-07-21 Knoll Ag Therapeutic agents
EP1194146B1 (en) 1999-06-18 2006-07-19 Merck & Co., Inc. Arylthiazolidinedione and aryloxazolidinedione derivatives
EP1076066A1 (en) 1999-07-12 2001-02-14 Zealand Pharmaceuticals A/S Peptides for lowering blood glucose levels
AU768310B2 (en) 1999-07-29 2003-12-04 Eli Lilly And Company Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists
AU774071B2 (en) 1999-09-01 2004-06-17 Sanofi-Aventis Deutschland Gmbh Sulfonyl carboxamide derivatives, method for their production and their use as medicaments
AU2001233622A1 (en) 2000-02-25 2001-09-03 Novo-Nordisk A/S Inhibition of beta cell degeneration
ATE369337T1 (de) 2000-04-28 2007-08-15 Asahi Kasei Pharma Corp Neue bizyklische verbindungen
CA2408486A1 (en) 2000-05-11 2001-11-15 Bristol-Myers Squibb Company Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
SE0001899D0 (sv) 2000-05-22 2000-05-22 Pharmacia & Upjohn Ab New compounds
HUP0004741A2 (hu) 2000-11-28 2002-12-28 Sanofi-Synthelabo Kémiai eljárás tiazolszármazékok előállítására és új intermedier
BR0116325A (pt) * 2000-12-21 2003-10-14 Aventis Pharma Gmbh 1,2-difenilazetidinonas, processos para a sua preparação, medicamentos contendo estes compostos e sua aplicação para o tratamento de distúrbios do metabolismo de lipìdios
DE10139416A1 (de) 2001-08-17 2003-03-06 Aventis Pharma Gmbh Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6884812B2 (en) 2001-08-31 2005-04-26 Aventis Pharma Deutschland Gmbh Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
ATE347890T1 (de) 2001-08-31 2007-01-15 Sanofi Aventis Deutschland Diarylcycloalkylderivate, verfahren zu ihrer herstellung und ihre verwendung als ppar- aktivatoren
US7176194B2 (en) * 2002-06-19 2007-02-13 Sanofi-Aventis Deutschland Gmbh Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
GB0215579D0 (en) * 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
ATE386020T1 (de) 2008-03-15
DK1862455T3 (da) 2009-06-02
AU2004226287A1 (en) 2004-10-14
UY28253A1 (es) 2004-11-08
CY1107398T1 (el) 2012-12-19
RU2334737C2 (ru) 2008-09-27
WO2004087655A1 (de) 2004-10-14
PA8599401A1 (es) 2004-10-08
CN1768034A (zh) 2006-05-03
AR043783A1 (es) 2005-08-10
US20050020563A1 (en) 2005-01-27
RS51146B (sr) 2010-10-31
PT1613589E (pt) 2008-03-27
EP1613589B1 (de) 2008-02-13
US7772429B2 (en) 2010-08-10
DE502004006195D1 (de) 2008-03-27
BRPI0408920A (pt) 2006-03-28
NI200500164A (es) 2006-01-11
ES2298731T3 (es) 2008-05-16
CL43489B (es) 2005-01-21
GT200400058A (es) 2004-11-10
TW200504009A (en) 2005-02-01
EP1862455B1 (de) 2009-02-25
DE502004009059D1 (de) 2009-04-09
KR20050119180A (ko) 2005-12-20
CR7995A (es) 2006-09-22
US7205290B2 (en) 2007-04-17
CN100361970C (zh) 2008-01-16
HK1087697A1 (en) 2006-10-20
SA04250154B1 (ar) 2007-10-29
ES2322876T3 (es) 2009-06-30
RU2005133631A (ru) 2006-03-10
HRP20050870A2 (en) 2006-10-31
JP2006522040A (ja) 2006-09-28
PL1862455T3 (pl) 2009-07-31
PT1862455E (pt) 2009-04-23
DE10314610A1 (de) 2004-11-04
AU2004226287B2 (en) 2010-03-18
SI1613589T1 (sl) 2008-06-30
EP1862455A2 (de) 2007-12-05
NZ542751A (en) 2007-05-31
ATE423766T1 (de) 2009-03-15
RS20050719A (en) 2008-04-04
US20070197498A1 (en) 2007-08-23
MA27753A1 (fr) 2006-02-01
EP1613589A1 (de) 2006-01-11
DK1613589T3 (da) 2008-06-09
CY1109055T1 (el) 2014-07-02
MY136269A (en) 2008-09-30
PE20050011A1 (es) 2005-02-28
HN2004000109A (es) 2008-02-21
ECSP056071A (es) 2006-01-27
CA2520689A1 (en) 2004-10-14
MXPA05010128A (es) 2005-11-16
ZA200506708B (en) 2007-01-31
TNSN05244A1 (en) 2007-06-11
UA80754C2 (en) 2007-10-25
JO2493B1 (en) 2009-10-05
EP1862455A3 (de) 2007-12-12
PL1613589T3 (pl) 2008-07-31
SV2004001756A (es) 2004-11-18
MEP41408A (en) 2011-02-10
NO20055001L (no) 2005-10-27
CN101139306A (zh) 2008-03-12

Similar Documents

Publication Publication Date Title
PT1862455E (pt) Ácido 11-((4r,6r)-4,5,6-tri-hidroxi-3-(r)-hidroxi-2-(s)- hidroxi-hexilcarbamoil)-undecanóico
IL175349A0 (en) 2-halogen-6-alkyl-phenyl substituted tetramic acid derivatives
AU2001281875A1 (en) Quinophthalone-derivative based crystallization modifiers
AU2003277159A8 (en) Short milk tube
GB0308988D0 (en) Molecule
AU2003902263A0 (en) Monosaccharide compounds
GB0328363D0 (en) Therapeutically useful molecules
EP1460081A4 (en) SUGAR DERIVATIVE
AU2002247017A1 (en) Compounds for treating pathologies associated with molecular crystallization
AU2003232036A8 (en) Nanoarchaeum nucleic acid molecule
EP1618893A4 (en) MEANS FOR INCREASING SUGAR CAPACITY
GB0306522D0 (en) Fastening mechanism
GB2402279B (en) Front end module
EP1695012A4 (en) EVAPORATOR
GB2400130A8 (en) Post driver
AU2003276655A1 (en) Pi - conjugated molecules
GB0225117D0 (en) Tubes for alcoholic drinks
GB2405826B (en) Sweet manufacture
EP1642079A4 (en) EVAPORATOR
EP1611000A4 (en) MANAGEMENT MECHANISM
GB0226654D0 (en) Carbonated vodka vo2
AU2003100350A4 (en) Bicycle rack
GB0208818D0 (en) Nucleic acid molecule
GB0108640D0 (en) Pasture enrichment
AU2003904694A0 (en) Purifying molecules